COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $128,304 | -38.5% | 16,200 | -25.3% | 0.00% | -50.0% |
| Q3 2022 | $208,537 | +40.9% | 21,700 | +88.7% | 0.00% | +100.0% |
| Q1 2022 | $148,000 | -63.6% | 11,500 | -54.9% | 0.00% | -66.7% |
| Q4 2021 | $407,000 | -60.2% | 25,500 | -59.9% | 0.00% | -70.0% |
| Q3 2021 | $1,022,000 | -15.3% | 63,600 | -27.1% | 0.01% | -16.7% |
| Q2 2021 | $1,207,000 | +7.0% | 87,300 | +13.1% | 0.01% | +9.1% |
| Q1 2021 | $1,128,000 | +60.2% | 77,200 | +90.6% | 0.01% | +57.1% |
| Q4 2020 | $704,000 | -21.5% | 40,500 | -17.2% | 0.01% | -30.0% |
| Q3 2020 | $897,000 | -9.3% | 48,900 | -11.7% | 0.01% | -16.7% |
| Q2 2020 | $989,000 | +18.2% | 55,400 | +7.4% | 0.01% | 0.0% |
| Q1 2020 | $837,000 | -27.9% | 51,600 | -20.0% | 0.01% | -7.7% |
| Q4 2019 | $1,161,000 | +39.4% | 64,500 | +56.9% | 0.01% | +44.4% |
| Q3 2019 | $833,000 | – | 41,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |